Samuel Wadsworth
Hoofd Techniek/Wetenschap/O&O bij ULTRAGENYX PHARMACEUTICAL INC.
Vermogen: 40 843 $ op 30-04-2024
Actieve functies van Samuel Wadsworth
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2017 | - |
PRECISION BIOSCIENCES, INC. | Directeur/Bestuurslid | 06-11-2021 | - |
Independent Dir/Board Member | 06-11-2021 | - |
Loopbaan van Samuel Wadsworth
Eerdere bekende functies van Samuel Wadsworth
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DIMENSION THERAPEUTICS INC | Hoofd Techniek/Wetenschap/O&O | 01-08-2013 | 01-11-2017 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-1993 | 01-01-2013 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - | - |
Opleiding van Samuel Wadsworth
The University of Chicago | Doctorate Degree |
Southern Illinois University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
PRECISION BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Dimension Therapeutics, Inc.
Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
- Beurs
- Insiders
- Samuel Wadsworth
- Ervaring